Cleared Special

K091157 - GLUCO LAB AUTO CODING, MODEL IGM-0022

K091157 is an FDA 510(k) clearance for GLUCO LAB AUTO CODING, manufactured by Infopia Co, Ltd.. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 210-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2009
Decision
210d
Days
Class 2
Risk

K091157 is an FDA 510(k) clearance for the GLUCO LAB AUTO CODING, MODEL IGM-0022. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Infopia Co, Ltd. (Santa Fe Springs, US). The FDA issued a Cleared decision on November 17, 2009 after a review of 210 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K091157

510(k) Number K091157 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2009
Decision Date November 17, 2009
Days to Decision 210 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
121d slower than avg
Panel avg: 89d · This submission: 210d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 513
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K091157.
DIDGET BLOOD GLUCOSE METER, MODEL 6181
K090628 · Bayer Healthcare, LLC · Dec 2009
LIPIDPRO SYSTEM
K090405 · Infopia Co, Ltd. · Dec 2009
MICRODOT XTRA
K083273 · Cambridge Sensors Limited · Nov 2009
SUPERCHECK 1 BLOOD GLUCOSE MONITORING SYSTEM, MODEL 6268
K091815 · Biotest Medical Corp. · Nov 2009
EASYPLUS MINI MASTERDRIVER SELF MONITORING BLOOD GLUCOSE SYSTEM, MODEL EPS09009
K092887 · Eps Bio Technology Corp. · Oct 2009
POCKETCHEM EZ BLOOD GLUCOSE MONITORING SYSTEM
K090653 · Arkray Factory USA, Inc. · Oct 2009